Literature DB >> 5697045

Fibrin breakdown products and fibrinolysis in renal disease.

E N Wardle, G Taylor.   

Abstract

In chronic renal failure and after acute renal failure, fibrinogen levels are raised and there is diminished fibrinolysis as the result of renal damage. A similar situation is found in nephrosis, possibly due to fibrinolytic inhibitors. Increased levels of cryofibrinogen were found in one quarter of cases of acute nephritis, nephrosis, and acute and chronic renal failure. In addition, after acute renal failure low platelet counts, prolonged thrombin times, and high levels of fibrin degradation products, yet with diminished fibrinolysis, indicate that intravascular coagulation has occurred. A positive result for fibrin degradation products was found in 17 of 20 cases of acute renal failure but in none of 10 cases of chronic uraemia. Intravascular coagulation is a process in which fibrin is deposited in the glomerular filters and may account for anuria, and, in the renal vasculature, where it may cause ischaemic tubular necrosis.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5697045      PMCID: PMC473708          DOI: 10.1136/jcp.21.2.140

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  FIBRINOLYTIC ACTIVITY IN PLASMA AND URINE IN CHRONIC RENAL DISEASE.

Authors:  N EDWARD; D P YOUNG; M MACLEOD
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

2.  COLD-PRECIPITABLE FIBRINOGEN, "CRYOFIBRINOGEN".

Authors:  H I GLUECK; L G HERRMANN
Journal:  Arch Intern Med       Date:  1964-05

3.  PLASMA FIBRINOLYTIC ACTIVITY IN RENAL DISEASE.

Authors:  G P MCNICOL; A A BARAKAT; A S DOUGLAS
Journal:  Scott Med J       Date:  1965-05       Impact factor: 0.729

Review 4.  THE COAGULATION PROCESS AND GLOMERULAR DISEASE.

Authors:  P VASSALLI; R T MCCLUSKEY
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

5.  An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states.

Authors:  H C FERREIRA; L G MURAT
Journal:  Br J Haematol       Date:  1963-07       Impact factor: 6.998

6.  The effect of citrate on euglobulin methods of estimating fibrinolytic activity.

Authors:  M BUCKELL
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

7.  Effects of fibrinogen degradation products on platelets and coagulation.

Authors:  M J Larrieu; V J Marder; S Inceman
Journal:  Thromb Diath Haemorrh Suppl       Date:  1966

8.  The kidneys and the liver as the organs regulating the fibrinolytic system of the circulating blood.

Authors:  T Januszko; M Furman; K Buluk
Journal:  Thromb Diath Haemorrh       Date:  1966-05-15

9.  Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors:  F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

10.  THE PATHOGENIC ROLE OF FIBRIN DEPOSITION IN THE GLOMERULAR LESIONS OF TOXEMIA OF PREGNANCY.

Authors:  P VASSALLI; R H MORRIS; R T MCCLUSKEY
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  13 in total

1.  The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen.

Authors:  Geoffrey R Nunns; Ernest E Moore; Michael P Chapman; Hunter B Moore; Gregory R Stettler; Erik Peltz; Clay C Burlew; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  Am J Surg       Date:  2017-09-18       Impact factor: 2.565

2.  Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.

Authors:  M Cronlund; J Hardin; J Burton; L Lee; E Haber; K J Bloch
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  [Disseminated intravascular coagulation following kidney allotransplantation. Diagnostic significance and therapeutic consequences].

Authors:  V Zühlke; E Quellhorst; E Hierholzer; G Mietzsch
Journal:  Klin Wochenschr       Date:  1972-04-01

4.  Studies on hypo- and hypercoagulability. II. Coagulation and fibrin analyses in severe infectious and toxic conditions.

Authors:  F Kunz; H Hörtnagl; G Kroesen; W Schennach; D Egg; E Rumpl; R Aschauer; F Holzknecht
Journal:  Blut       Date:  1974-05

5.  Study of proteins and fibrinolysis in patients with glomerulonephritis.

Authors:  E N Wardle; I S Menon; S P Rastogi
Journal:  Br Med J       Date:  1970-05-02

6.  Serum and urine F.R.-antigen in renal disease.

Authors:  E N Wardle
Journal:  Br Med J       Date:  1972-11-18

7.  Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease.

Authors:  H Ekert; T M Barratt; C Chantler; M W Turner
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

8.  Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J J Petrie; J D Cash; J S Robson
Journal:  Br Med J       Date:  1971-08

9.  [Goodpasture's syndrome: immunofluorescence studies of the lung (author's transl)].

Authors:  V Misgeld; H J Bungert; W Höfer
Journal:  Pneumonologie       Date:  1976-06-25

10.  Renal vein thrombosis complicating lipoid nephrosis.

Authors:  C G Elliott; M E Hammond; R E Bond; R O Crapo
Journal:  West J Med       Date:  1982-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.